Litigation Details for CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD. (D.N.J. 2017)
✉ Email this page to a colleague
CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD. (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-09-06 |
Court | District Court, D. New Jersey | Date Terminated | 2019-09-05 |
Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Parties | LOTUS PHARMACEUTICAL CO., LTD. | ||
Patents | 6,045,501; 6,315,720; 6,561,977; 6,755,784; 7,189,740; 7,465,800; 7,765,106; 7,765,107; 7,855,217; 7,895,059; 7,968,569; 8,112,290; 8,315,886; 8,404,717; 8,457,988; 8,530,498; 8,589,182; 8,626,531; 8,645,160; 8,648,095; 8,731,963; 9,056,120; 9,101,621; 9,101,622 | ||
Attorneys | AARON SCOTT ECKENTHAL; BRIAN JOHN FORSATZ; CHARLES MICHAEL LIZZA; DAVID LEIGH MOSES; FRANK CHARLES CALVOSA; GARRETT E. BROWN , JR.; SARAH ANN SULLIVAN; TEDD WILLIAM VAN BUSKIRK; WILLIAM C. BATON; WILLIAM L. MENTLIK | ||
Firms | Lerner, David, Littenberg, Krumholz & Mentlik, LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD.
Biologic Drugs cited in CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD.
Details for CELGENE CORPORATION v. LOTUS PHARMACEUTICAL CO., LTD. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-09-06 | 1 | expiration of United States Patent Nos. 5,635,517 (“the ʼ517 patent”); 6,315,720 (“the ʼ720 … 35 PageID: 2 patent”); 6,561,977 (“the ʼ977 patent”); 6,755,784 (“the ʼ784 patent”); 7,189,740 (“the…“the ʼ740 patent”); 7,465,800 (“the ʼ800 patent”); 7,855,217 (“the ʼ217 patent”); 7,968,569 (“the ʼ569…ʼ569 patent”); 8,315,886 (“the ʼ886 patent”); 8,404,717 (“the ʼ717 patent”); 8,530,498 (“the ʼ498 patent…,531 (“the ʼ531 patent”); 8,648,095 (“the ʼ095 patent”); 9,056,120 (“the ʼ120 patent”); 9,101,621 (“the | External link to document | |
2019-01-30 | 101 | Covenant Not to Sue for Infringement of U.S. Patent No. 7,855,217 (Attachments: # 1 Certificate of Service… 5 September 2019 2:17-cv-06842 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
2019-02-21 | 105 | BIFURCATION AND STAY WITH RESPECT TO U.S. PATENT NOS. 6,315,720, 6,561,977, 6,775,784, 8,315,886 AND 8,626,531… 5 September 2019 2:17-cv-06842 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |